Cagnes sur Mer, France

Julien Saldo

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: A Profile of Inventor Julien Saldo

Introduction: Julien Saldo, an accomplished inventor based in Cagnes sur Mer, France, has made significant contributions to the field of ophthalmology. With a total of four patents to his name, he has focused on innovative solutions that enhance the effectiveness of ophthalmic compositions, which are crucial for treating various eye conditions.

Latest Patents: Among Julien's latest inventions is an ophthalmic composition that contains a nitric oxide releasing prostamide. This invention provides aqueous ophthalmic compositions in the form of a solution comprising hexanoic acid, 6-(nitrooxy)-, and several other complex compounds. Notably, the solution utilizes macrogol 15 hydroxystearate as the sole solubilizing agent, contributing to its efficacy and ease of use in medical applications.

Career Highlights: Julien Saldo is associated with Nicox S.A., a company known for its focus on developing eye care treatments. His innovative work within the company has solidified his position as a key figure in ophthalmic research and development. His patented inventions underscore the commitment to enhancing patient outcomes in eye healthcare.

Collaborations: Throughout his career, Julien has worked alongside esteemed colleagues, including Frédéric Pilotaz and Alan L. Weiner. These collaborations have been instrumental in fostering a dynamic environment for innovation and pushing the boundaries of what is possible in ophthalmic treatments.

Conclusion: Julien Saldo continues to be a driving force in the field of ophthalmology through his inventive spirit and collaborative efforts. His notable patents serve as a testament to his dedication and expertise, promising advancements in eye care that will benefit countless individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…